Affiliation:
1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281,
Indonesia
2. Curcumin Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
Abstract
Background:
Clodronate, a non-nitrogen-containing bisphosphonate (non-NBP), is intracellularly
converted into non-hydrolyzable ATP analogs. Clodronate and its analogs impair normal cell
functions, including the exocytosis process. However, how this occurs in mast cells is still not well
characterized.
Objective:
To summarize the possible mechanisms of clodronate-mediated exocytosis inhibition in mast
cells.
Results:
Non-NBPs display several possible mechanisms of exocytosis inhibition in various cell types,
including vesicular nucleotide transporter (VNUT) and purinergic receptor inhibition. Inhibition of purinergic
receptors has been shown in mast cells, but VNUT inhibition remains to be confirmed. Inhibition
of protein prenylation by non-NBPs has also been shown; however, direct evidence of non-NBPs in
prenylated exocytosis proteins is still contradictory. Finally, non-NBPs may inhibit mast cell exocytosis
via impairment of protein pyrophosphorylation. This mechanism is less studied, and direct evidence of
the involvement of pyrophosphorylated proteins in exocytosis is still lacking.
Conclusions:
Non-NBPs may affect mast cell exocytosis by interacting with purinergic receptors or
VNUT or by preventing post-translational modifications of exocytosis protein(s), i.e., prenylation and
pyrophosphorylation. The latter needs further investigation to provide direct evidence of a role for non-
NBPs.
Publisher
Bentham Science Publishers Ltd.
Subject
Cell Biology,Molecular Biology,Biochemistry,General Medicine